Sue Desmond-Hellmann: A smarter, more precise way to think about public health
Su Dezmond-Helman (Sue Desmond-Hellmann): Pametniji, precizniji način za razmišljanje o javnom zdravlju
Sue Desmond-Hellmann leads the Bill & Melinda Gates Foundation’s mission to establish equity for every person. Full bio
Double-click the English transcript below to play the video.
Theresa Marie.
and Kevin Michael's on his right.
a Kevin Majkl je desno od njega.
was picking names.
bila mi je biranje imena.
number seven came along,
kada je došlo sedmo dete,
on Jennifer Bridget.
oko Dženifer Bridžet.
ceremonial moment.
u tom posebnom svečanom momentu.
for their new babies
za svoje novorođene bebe
of this special ceremonial time?
ovaj poseban svečani trenutak?
bearable without a name.
malo podnošljiviji bez imena.
dreaming of the future of that child --
sanjarenja o budućnosti deteta -
of a future for their child
o budućnosti svog deteta
an updated pie chart.
ažurirani kružni grafikon.
under five worldwide."
ispod pet godina širom sveta.“
of that pie chart, about 40 percent --
kružnog grafikona, oko 40 procenata -
is less than one month old.
ima manje od mesec dana.
"We have no idea."
„Nemamo pojma.“
what you can't define.
ono što ne možete definisati.
the dreams of those parents
u obnavljanju snova tih roditelja
about a new approach,
o novom pristupu,
know why babies are dying,
da saznamo zašto bebe umiru,
from a very special place.
proističe sa vrlo posebnog mesta.
an oncologist.
kao lekar za rak, onkolog.
to help people feel better.
da pomognem da ljudima bude bolje.
made them feel worse.
im je od mojih tretmana bilo lošije.
being driven to my clinic
koje su dovozile u moju kliniku
into my exam room by their mothers.
da pomažu da dođu do moje ordinacije.
in the war on cancer,
u ratu protiv raka,
couldn't differentiate
nisu mogla da razlikuju
that we wanted to hit hard
da žestoko napadnemo
that we wanted to preserve.
koje smo hteli da sačuvamo.
all very familiar with --
sa kojima ste svi upoznati -
so infection was a constant threat --
stalna pretnja od infekcije -
to the biotechnology industry.
u industriju biotehnologije.
for breast cancer patients
za pacijente sa rakom dojke
of telling the healthy cells
ili ćelija raka.
HER2-positive breast cancer,
HER2 pozitivni rak dojke,
form of breast cancer.
bila najstrašnija vrsta raka dojke.
hit hard the cancer cells,
da žestoko napadnemo ćelije raka,
gentle on the normal cells.
i nežniji smo prema njima.
gene sequencing and more --
sekvenciranje gena i više od toga -
širokim spektrom bolesti.
da ka pojedincima usmerimo
revolutionized cancer therapy.
revoluciju u lečenju raka.
better way to tackle diseases
za bavljenje bolestima
expensive medicines like Herceptin
kao što je Herceptin
targeting for individuals
problemima javnog zdravlja
you're thinking, "She's crazy.
To je suviše ambiciozno.“
to make a big difference.
as a cancer doctor.
kao doktor za rak.
who trained in San Francisco in the '80s,
obrazovani u San Francisku '80-ih godina,
a terrible global challenge.
are living with HIV.
živi sa HIV virusom.
become pregnant,
until the age of two.
neće doživeti uzrast od dve godine.
can virtually guarantee
može praktično da garantuje
the virus to the baby.
kind of like that blast of chemo,
nekako poput tog udara hemoterapije,
every pregnant woman in the world.
svaku trudnicu na svetu.
where HIV rates are the highest.
gde su stope HIV virusa najviše.
in sub-Saharan Africa
u Podsaharskoj Africi
where rates are highest.
gde su stope najviše.
to a public health problem
problemu javnog zdravlja
u određenim oblastima zemalja u razvoju
in certain areas in the developing world
can change things on a big scale.
može da promeni stvari na širokom planu.
elements of precision public health:
preciznog javnog zdravlja:
to the 2.6 million babies
jednostavno ne znamo.
the causes of infant mortality
uzroke mortaliteta novorođenčadi
with the highest infant mortality
sa najvećim mortalitetom novorođenčadi
who has just lost her child,
koja je upravo izgubila dete:
Did they have a fever?"
Da li je imala temperaturu?“
after the baby has died.
in the shoes of that mom.
excruciating conversation.
nije baš od naročite pomoći,
there was a fever or vomiting,
temperature ili povraćanja,
that knowledge,
da ta majka, ta porodica,
a precision public health approach?
pristup preciznog javnog zdravlja?
da u određenim oblastima u Africi
because of a bacterial infection
mom has a seven times higher chance
mama ima sedam puta veće izglede
we can prevent that death
možemo sprečiti tu smrt
and safe as penicillin.
poput penicilina.
the right interventions
možemo doneti prave intervencije
in the right places
and with these interventions
our 15-year goal.
naš petnaestogodišnji cilj.
into a million babies' lives saved
u milion spasenih života beba
to public health --
tackle malnutrition?
efikasnije bavili neuhranjenošću?
cervical cancer in women?
rak grlića materice kod žena?
in two different worlds,
by public health professionals.
profesionalci u oblasti javnog zdravlja.
about precision public health
u vezi sa preciznim javnim zdravljem
talent and tools --
in ways I never imagined
na načine za koje nikada nisam mislila
that kind of talent and tools
takve talente i sredstva
u siromašom svetu.
the confidence
the moment that child is born,
onog trenutka kada se to dete rodi,
will be measured in decades,
o tome da će se život tog deteta
ABOUT THE SPEAKER
Sue Desmond-Hellmann - CEO, Gates FoundationSue Desmond-Hellmann leads the Bill & Melinda Gates Foundation’s mission to establish equity for every person.
Why you should listen
As CEO of the Bill & Melinda Gates Foundation, Sue Desmond-Hellmann leads the organization's vision for a world where every person has the opportunity to live a healthy, productive life. Drawing on her diverse experience as scientist, physician and business executive, she oversees a variety of missions focused on eradicating disease, poverty and inequity. She leads 1,400 people, across four continents, working in more than 100 countries to help more children and young people survive and thrive, combat infectious diseases that hit the poorest hardest, and empower people -- particularly women and girls -- to transform their lives.
Trained as an oncologist, Dr. Desmond-Hellmann spent 14 years at biotech firm Genentech, developing a number of breakthrough medicines, including two of the first gene-targeted therapies for cancer, Avastin and Herceptin. In November 2009, Forbes magazine named her one of the world's seven most "powerful innovators," calling her "a hero to legions of cancer patients." Her time at Genentech put her at the forefront of the precision medicine revolution, and in her current role she champions a similar approach to global development: precision public health -- getting the right interventions, to the right populations, in the right places, to save lives.
Immediately prior to joining the foundation in 2014, Dr. Desmond-Hellmann was the first female chancellor of the University of California at San Francisco (UCSF), overseeing all aspects of the university and medical center's strategy and operations. It was her second stint at UCSF, having completed her clinical training there in the 1980s. She moved to Uganda in 1989 to work on HIV/AIDS and cancer, which she credits as a turning point in her career. "It was so profound to recognize ... that all the learning I had done to become a doctor didn't matter at all if I didn’t make a contribution," she said.
Dr. Desmond-Hellmann is the recipient of numerous honors and awards. She was listed among Fortune magazine's "50 most powerful women in business" for seven years. In 2010, she was inducted into the American Academy of Arts and Sciences and elected to the Institute of Medicine. She serves on the boards of directors at Facebook Inc. and the Procter & Gamble Company.
Sue Desmond-Hellmann | Speaker | TED.com